McKesson Corporation (LON:0JZU)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 75.13B |
| Revenue (ttm) | 287.97B |
| Net Income (ttm) | 3.00B |
| Shares Out | n/a |
| EPS (ttm) | 23.89 |
| PE Ratio | 25.04 |
| Forward PE | 20.00 |
| Dividend | 2.32 (0.28%) |
| Ex-Dividend Date | Dec 1, 2025 |
| Volume | 132 |
| Average Volume | 535 |
| Open | 817.35 |
| Previous Close | 823.94 |
| Day's Range | 814.03 - 824.70 |
| 52-Week Range | 562.51 - 899.40 |
| Beta | 0.41 |
| RSI | 48.11 |
| Earnings Date | Feb 4, 2026 |
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]
Financial Performance
In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.
Financial numbers in USD Financial StatementsNews
Insider Sell: Thomas Rodgers Sells Shares of McKesson Corp (MCK)
Insider Sell: Thomas Rodgers Sells Shares of McKesson Corp (MCK)
Final Trades: Lockheed Martin, QXO and McKesson Corporation
CNBC's “Halftime Report” Investment Committee discuss their top stocks to watch for the second half of the day's trading session.
McKesson Builds Earnings Momentum on Specialty and Automation
McKesson posts a strong fiscal second quarter, lifts full-year EPS outlook, and shows how specialty growth and automation are reshaping its earnings power.
Final Trades: Lockheed Martin, QXO and McKesson Corporation
CNBC’s “Halftime Report” Investment Committee discuss their top stocks to watch for the second half of the day's trading session.
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recomme...
RWL, MCK, COR, CAH: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Revenue ETF (Symbol: RWL) where we have detected an ap...
McKesson Corporation: FY26 Earnings Visibility Underpins Buy Case
Validea Detailed Fundamental Analysis - MCK
Below is Validea's guru fundamental report for MCKESSON CORP (MCK). Of the 22 guru strategies we follow, MCK rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Mckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2026 financial results after market close on Wednesday, February 4, 2026. The company will host a...
McKesson: I Expect A Significant Slowdown In 2026
McKesson saw strong 2025 growth from GLP-1 tailwinds, but fading momentum, weak margins, and a 21x forward P/E show contraction. Read why MCK stock is a sell.
Our Top 10 High-Growth Dividend Stocks - December 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
Interesting MCK Put And Call Options For August 2026
Investors in McKesson Corp (Symbol: MCK) saw new options become available today, for the August 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, ...
McKesson (MCK) Rises As Market Takes a Dip: Key Facts
McKesson (MCK) reached $823.01 at the closing of the latest trading day, reflecting a +1.13% change compared to its last close.
If You Invested $100 In McKesson Stock 20 Years Ago, You Would Have This Much Today
McKesson (NYSE: MCK) has outperformed the market over the past 20 years by 5.99% on an annualized basis producing an average annual return of 14.76%. Currently, McKesson has a market capitalization o...
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Barclays Initiates Coverage on McKesson (MCK) with Overweight Rating | MCK Stock News
Barclays Initiates Coverage on McKesson (MCK) with Overweight Rating | MCK Stock News
Illinois Rep. Jonathan Jackson Sold Up to $80K Worth of Doximity Stock
Records from December 5, 2025 indicate that Representative Jonathan Jackson of Illinois made a sale of Doximity (NYSE: DOCS), valued between $17,003 and $80,000, with the transaction dated November 6...
If You Invested $1000 In McKesson Stock 5 Years Ago, You Would Have This Much Today
McKesson (NYSE: MCK) has outperformed the market over the past 5 years by 21.85% on an annualized basis producing an average annual return of 34.98%. Currently, McKesson has a market capitalization o...
McKesson Corp at Evercore ISI Healthcare Conference Transcript
McKesson Corp at Evercore ISI Healthcare Conference Transcript
McKesson Corporation (MCK) Presents at Evercore 8th Annual Healthcare Conference Transcript
Guru Fundamental Report for MCK
Below is Validea's guru fundamental report for MCKESSON CORP (MCK). Of the 22 guru strategies we follow, MCK rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Noteworthy ETF Outflows: USMV, MCK, COR, WM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI USA Min Vol Factor ETF (Symbol: USMV) where we have detec...
McKesson's Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care
IRVING, Texas--(BUSINESS WIRE)--McKesson published its first-ever Advancing Community Oncology Report, a look at the trends influencing community oncology practices across the U.S.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
3 Reasons Growth Investors Will Love McKesson (MCK)
McKesson (MCK) could produce exceptional returns because of its solid growth attributes.